Understanding how mitochondria contribute to lens fibrosis after cataract surgery
Investigating the role of mitochondrial function in driving lens fibrotic disease
This study is looking at how tiny parts of our cells called mitochondria might play a role in a common issue called Posterior Capsule Opacification (PCO) that can happen after cataract surgery, with the hope that understanding this could help create better treatments or ways to prevent it for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10889642 on NIH RePORTER |
What this research studies
This research investigates the role of mitochondria in the development of Posterior Capsule Opacification (PCO), a common complication following cataract surgery. By examining how mitochondrial function and remodeling affect lens cells, the study aims to uncover the molecular mechanisms that lead to fibrosis in the lens. The approach includes analyzing gene expression changes and mitochondrial behavior in a model that mimics PCO, focusing on how these factors contribute to the disease process. Patients may benefit from insights that could lead to improved treatments or preventive strategies for PCO.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone cataract surgery and are at risk for developing Posterior Capsule Opacification.
Not a fit: Patients who have not had cataract surgery or do not have a history of lens fibrotic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to prevent or treat lens fibrosis after cataract surgery.
How similar studies have performed: Other research has shown promising results in understanding mitochondrial roles in various fibrotic diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Walker, Janice Lynn — Thomas Jefferson University
- Study coordinator: Walker, Janice Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.